Resume

• 1980

  Dr. Ken Wilson started GP rounds with his Dad at age 3

  went to the local primary school in Kirkliston

  then to George Watson’s Boys’ College

  Edinburgh from 1953-1963

  where he won House Colors at Rugby and twice won the Highland Watsonian Club Quaich for individual highland bagpipe. At Edinburgh University

  he qualified Bachelor of Medical Science (Hons. Pharmacology) 1967

  MBChB 1970 and Doctorate (MD) 1994 with a Thesis on Cutaneous Malignant Melanoma. He trained in Internal Medicine in Edinburgh Royal Infirmary and became Member of the Royal Colleges of Physicians of the UK in 1972. In 1977 he emigrated to Canada and the Saskatchewan Cancer Foundation where be began his career in Medical Oncology. In 1979

  he became one of the first 2 board certified Medical Oncologists (ABIM

  Med Onc) in the province. He moved to the Victoria Cancer Clinic in 1980 where he was the only full time specialist in Medical Oncology for 8 years. He became FRCPC in 1978

  FACP 1980

  FRCP Edinburgh in 1985. Dr Wilson was appointed Clinical Professor of Medicine at the University of British Columbia in 2006. He has broad oncology interests with principal author publications in all major tumor types (Lancet

  BMJ

  Cancer Investigation

  Leukemia and Lymphoma

  Cancer Treatment Reports etc). He has been closely linked to the NCIC Myeloma and Melanoma Groups

  and authored the report of the 3rd NCIC Myeloma Trial. Along with Dr. Jan Lim

  he introduced radical CTRT for esophageal cancer in the BC Cancer Agency. His main non-medical interest is music. He was Medical Officer and Guest Piper with the N Sask R and Canadian Scottish Regiments from 1977 – 1984

  and is currently a Member of the Royal Scottish Pipers’ Society and guest member of the Can Scots Association Pipes and Drums

  He married Sally (d 2015)

  who trained in Nursing and Midwifery in Edinburgh

  has 3 children

  one a high school Teacher

  one a Public Relations professional

  and one Head of Campus Planning and Sustainability

  UVic.

  Kenneth

  Wilson

  BC Cancer Agency

  Latterly

  Prince George

  BC

  Clinical Professor of Medicine

  University of British Columbia

  BC Cancer Agency

  Also: Andrew Carnegie Trust Travelling Scholar to University of Illinois

  Chicago 1969.\nGunning Vacation Scholarship in Brain Metabolism 1966.

  Edinburgh University

• 1963

  Bachelor of Medicine

  Bachelor of Surgery (M.B.B.S.)

  Doctor of Medicine (MD)

  BSc Hons Pharmacology 1967

  MBChB 1970

  MD Thesis Cutaneous Malignant Melanoma 1994

  Edinburgh University Officers Training Corps Pipes and Drums

  The University of Edinburgh

  Medical Oncology

  Royal College of Physicians and Surgeons of Canada

  Medical Oncology

  American Board of Internal Medicine

  Internal Medicine

  Royal College of Physicians and Surgeons of Canada

• Patient Safety

  Clinical Trials

  Healthcare

  Medical Education

  Healthcare Information Technology

  Public Health

  Medicine

  Informatics

  Clinical Research

  Epidemiology

  Research

  Healthcare Management

  Hospitals

  Oncology

  Cancer

  Hypothalamic pituitary adrenal function in patients treated with intermittent high dose prednisone and cytotoxic chemotherapy

  C E Gray

  A C Parker

  J Seth

  E H D Cameron

  Hypothalamic pituitary adrenal function in patients treated with intermittent high dose prednisone and cytotoxic chemotherapy

  R D Gascoyne

  B Skinnider

  R Klasa

  K K Gill

  J M Connors

  M Chhanabhai

  B Berry

  L H Sehn

  CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma (DLBCL)

  H Assi

  Immune toxicities and long remission duration following ipilimumab therapy for metastatic melanoma: two illustrative cases

  Regression of follicular lymphoma with Devil’s Claw; coincidence or causation?

  Kong Khoo

  Amil Shah

  The British Columbia Compassionate Access Program: outcome analysis of esophago-gastric cancer patients

  Anthracyclines in early breast cancer

  Suzanne Malfair Taylor

  Raltitrexed: Optimism and reality

  Rami Kotb

  Is tremelimumab beneficial in advanced melanoma?

  K E Khoo

  Sharlene Gill

  C A Fitzgerald

  Adjuvant therapy with raltitrexed in patients with colorectal cancer intolerant of 5-fluorouracil: British Columbia Cancer Agency experience

  A D Toft

  W J Irvine

  Adrenocortical stimulation by substituted alpha 1 18 corticotrophin

  Ipilimumab plus DTIC in melanoma